Monday, December 22, 2025 | 02:44 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Page 21 - Healthcare Sector

Temasek backs future funds of impact investor LeapFrog with $500 mn

In India, LeapFrog has so far deployed capital across nine companies

Temasek backs future funds of impact investor LeapFrog with $500 mn
Updated On : 10 Mar 2021 | 2:49 AM IST

Supply challenges for auto-disable syringe needle private hospitals

So far, the syringes were being supplied by the state government

Supply challenges for auto-disable syringe needle private hospitals
Updated On : 04 Mar 2021 | 8:24 AM IST

Healthcare startup Innovaccer's valuation crosses $1 bn, joins unicorn club

The new funding round brings the total capital raised by Innovaccer to over $225 million.

Healthcare startup Innovaccer's valuation crosses $1 bn, joins unicorn club
Updated On : 26 Feb 2021 | 2:31 AM IST

Govt working to improve ease of doing biz in pharma sector: Minister

The government is continuously working to reduce regulatory compliance burden on the pharma industry in a bid to improve ease of doing business in the country, Union Minister for Chemicals & Fertilisers D V Sadananda Gowda said on Thursday. Addressing the inaugural session of 'The India Pharma 2021 & India Medical Device 2021' event here, the minister also emphasised that the domestic pharma industry has the capability to achieve the target of USD 130 billion turnover by 2030. "Under the leadership of Prime Minister Narendra Modi, the government continues to strive to improve the ease of doing business in the country. Vigorous effort is on to reduce the regulatory compliance burden on the (pharma) industry," Gowda said. Minister of State for Chemicals and Fertilisers Mansukh Mandaviya said that reforms are being undertaken by the government especially in the pharmaceutical sector. "In ease of doing business we have reached 79thposition now from the earlier 145. In the pharma ..

Govt working to improve ease of doing biz in pharma sector: Minister
Updated On : 25 Feb 2021 | 3:59 PM IST

Sun Pharma to launch complete range of generic anti-epilepsy drug

The firm said it plans to introduce a complete range of anti-epilepsy drug Brivaracetam in the country at an affordable price

Sun Pharma to launch complete range of generic anti-epilepsy drug
Updated On : 23 Feb 2021 | 3:59 PM IST

From best to worst: A 2020 winner in stock market is now the biggest loser

Health care is Asia's worst-performing sector this year

From best to worst: A 2020 winner in stock market is now the biggest loser
Updated On : 23 Feb 2021 | 2:31 AM IST

MediBuddy raises $20mn funding from India Life Sciences Fund III, others

The firm raised $20 million (about Rs 145 crore) earlier this month from India Life Sciences Fund III, LLC and others

MediBuddy raises $20mn funding from India Life Sciences Fund III, others
Updated On : 22 Feb 2021 | 7:28 PM IST

India to test efficacy of Covid-19 vaccines against SA, Brazil strains

There are not enough number of cases with the South African and Brazilian strains in the country to check the efficacy

India to test efficacy of Covid-19 vaccines against SA, Brazil strains
Updated On : 19 Feb 2021 | 11:04 PM IST

Walmart investors eye push into advertising, healthcare after pandemic boom

Walmart will report fourth-quarter results on Thursday

Walmart investors eye push into advertising, healthcare after pandemic boom
Updated On : 17 Feb 2021 | 7:42 PM IST

MediBuddy raises Rs 25 crore debt fund from InnoVen Capital

Digital healthcare platform MediBuddy has raised Rs 25 crore debt fund from InnoVen Capital

MediBuddy raises Rs 25 crore debt fund from InnoVen Capital
Updated On : 16 Feb 2021 | 7:51 PM IST

It's online all the way: The rise and rise of telemedicine amid Covid-19

Covid-19 gave a huge fillip to remote medical consultations, and the trend is likely to stay

It's online all the way: The rise and rise of telemedicine amid Covid-19
Updated On : 08 Feb 2021 | 6:10 AM IST

Biocon Biologics inks pact to expand access to its cancer biosimilars

Biocon Biologics is an arm of biotechnology major Biocon

Biocon Biologics inks pact to expand access to its cancer biosimilars
Updated On : 04 Feb 2021 | 7:41 PM IST

Indegene's valuation reaches $700 mn; raises $200 mn from Carlyle, Brighton

Given the wider adoption of digital initiatives within the healthcare industry, Indegene plans to use the funds to accelerate its M&A (merger and acquisition) and global expansion plans

Indegene's valuation reaches $700 mn; raises $200 mn from Carlyle, Brighton
Updated On : 03 Feb 2021 | 1:45 AM IST

Why pharma stocks are underperforming despite Rs 2.23 trn Budget allocation

Much of the increase in this year's Budget allocation for health and well-being is attributed to expenditure set aside for Covid-19 vaccination

Why pharma stocks are underperforming despite Rs 2.23 trn Budget allocation
Updated On : 02 Feb 2021 | 12:40 PM IST

'Get well soon' outlay: Health care gets best-ever shot in Budget 2021

Allocation jumps 118% over RE to Rs 2.23 trillion; Rs 35,000 cr earmarked for Covid vaccination

'Get well soon' outlay: Health care gets best-ever shot in Budget 2021
Updated On : 02 Feb 2021 | 1:10 AM IST

Budget: Vardhan says health vital to Atmanirbhar Bharat, hails 137% hike

Harsh Vardhan hailed the budget proposals concerning the health sector and "health and well-being" was on the top of the six prominent pillars of Atmnanirbhar Bharat outlined in Sitharaman's speech.

Budget: Vardhan says health vital to Atmanirbhar Bharat, hails 137% hike
Updated On : 02 Feb 2021 | 12:09 AM IST

Atmanirbhar campaign in sync with globalisation, PM tells MNC heads

Says India to soon supply two vaccines to the world, many more will come, going forward

Atmanirbhar campaign in sync with globalisation, PM tells MNC heads
Updated On : 29 Jan 2021 | 1:03 AM IST

Govt likely to set up Pradhan Mantri health fund in upcoming Budget

Centre, states to contribute to meet higher public spending target

Govt likely to set up Pradhan Mantri health fund in upcoming Budget
Updated On : 25 Jan 2021 | 6:10 AM IST

New product launches to drive growth for Lupin, US business a key trigger

This should reverse the US underperformance in FY15-20 with margins too moving up sharply

New product launches to drive growth for Lupin, US business a key trigger
Updated On : 18 Jan 2021 | 9:36 PM IST

Strong deal pipeline, auto sector recovery positive for Tata Elxsi

A 56 per cent stock uptick since December caps upside

Strong deal pipeline, auto sector recovery positive for Tata Elxsi
Updated On : 15 Jan 2021 | 12:36 AM IST